PTHvsBBPETF Comparison
VS
Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. PTH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, BBP's top sector exposures are Healthcare. PTH is more expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.34% for BBP. PTH is up 24.18% year-to-date (YTD) with +$131M in YTD flows. BBP performs better with 33.51% YTD performance, and +$50M in YTD flows. Run a side-by-side ETF comparison of PTH and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PTH vs BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/08/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PTH BBP | +1.24%+5.27% | +26.10%+26.69% | +24.18%+33.51% | +56.23%+51.93% | +74.28%+101.25% | +10.24%+103.38% |
| Flows | PTH BBP | +$26M+$5M | +$142M+$20M | +$131M+$50M | +$138M+$62M | +$78M+$68M | -$151M+$61M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PTH BBP | +28.96%+25.82% | +26.07%+25.10% | +26.02%+24.71% | +25.76%+26.60% |
| Max drawdown | PTH BBP | -7.42%-9.34% | -11.91%-9.59% | -27.71%-25.54% | -49.87%-37.61% |
| Max drawdown duration | PTH BBP | 40d39d | 140d48d | 353d292d | 1735d586d |
Trading data
PTH | BBP | |
Last sale 9/9/2026 at 1:30 PM | $61.46 | $105.52 |
| Previous close 09/08/2026 | $61.72 | $106.71 |
| Consolidated volume 09/08/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PTH | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/9/2026 at 1:30 PM
Live
Closed
PTH | BBP | |
|---|---|---|
| Last price | $61.46 | $105.52 |
| 1D performance | -0.42% | -1.12% |
| AuM | $288.30 M | $117.14 M |
| E/R | 0.72% | 0.34% |
Characteristics
PTH | BBP | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | VIRTUS Investment Partners |
| Benchmark | Dorsey Wright Healthcare Technical Leaders Index | LifeSci Biotechnology Products Index |
| N° of holdings | 54 | 66 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 12, 2006 | December 16, 2014 |
| ESG | No | No |
Exposure
Countries
PTH
USA
89.98%
Other
10.02%
BBP
USA
86.5%
Other
13.5%
Sectors
PTH
Healthcare
99.16%
Other
0.84%
BBP
Healthcare
98.2%
Other
1.8%
Diversification
PTH
Total weight of top 15 holdings out of 15
47.09%
BBP
Total weight of top 15 holdings out of 15
26.78%
Top 15 holdings
Data as of July 31, 2026
PTH
Roivant Sciences Ltd.
4.88%
Revolution Medicines, Inc.
4.85%
BrightSpring Health Services, Inc.
4.77%
Guardant Health, Inc.
4.50%
Axsome Therapeutics, Inc.
4.38%
Liquidia Corp.
3.17%
Erasca, Inc.
2.92%
Oruka Therapeutics, Inc.
2.54%
10X Genomics, Inc.
2.27%
Relay Therapeutics, Inc.
2.23%
Travere Therapeutics, Inc.
2.18%
Agilon Health, Inc.
2.13%
Oscar Health, Inc.
2.09%
Arrowhead Pharmaceuticals, Inc.
2.09%
Tango Therapeutics, Inc.
2.09%
BBP
Crinetics Pharmaceuticals, Inc.
3.24%
Verastem, Inc.
1.98%
Nuvation Bio, Inc.
1.80%
Omeros Corp.
1.73%
Geron Corp.
1.72%
BridgeBio Pharma, Inc.
1.68%
Agios Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
BeOne Medicines Ltd.
1.64%
Kiniksa Pharmaceuticals International Plc
1.63%
Precigen, Inc.
1.62%
Xeris Biopharma Holdings, Inc.
1.61%
ACADIA Pharmaceuticals, Inc.
1.60%
Iovance Biotherapeutics, Inc.
1.60%
Rhythm Pharmaceuticals, Inc.
1.60%
Frequently asked questions about PTH and BBP
How have the PTH and BBP ETFs performed in 2026?
As of September 8, 2026, PTH is up 24.18% year-to-date (YTD), while BBP has returned 33.51%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: PTH or BBP?
Year-to-date, the PTH ETF saw +$131M in flows, compared to +$50M for BBP.
Which ETF is more volatile: PTH or BBP?
Over the past year, PTH had a volatility of 26.07%, while BBP experienced 25.1%.
Which ETF is bigger: PTH or BBP?
As of September 8, 2026, PTH holds $288.30 M in assets under management (AUM), while BBP manages $117.14 M.
What sectors do the PTH and BBP ETFs invest in?
PTH leans toward sectors like Healthcare. Meanwhile, BBP focuses on Healthcare.
What are the top holdings of the PTH ETF and BBP ETF?
PTH top holdings include Roivant Sciences Ltd., Revolution Medicines, Inc. and BrightSpring Health Services, Inc.. BBP holds in its top three: Crinetics Pharmaceuticals, Inc., Verastem, Inc. and Nuvation Bio, Inc..
Which ETF is more diversified: PTH or BBP?
PTH holds 54 securities with 47.09% of its assets in the top 15. BBP has 66 securities and a top 15 weight of 26.78%.
Advertisement
Latest news about PTH & BBP
Advertisement
